Brief: Amgen Posts Q4 Total Rev $9.87 Bln VS IBES Estimate $9.47 Bln

Amgen

03/02/2026 21:01

Feb 3 (Reuters) - Amgen Inc AMGN.O:

AMGEN OUTLOOK FY26 ADJUSTED EPS $21.60-$23.00 VERSUS IBES ESTIMATE $22.09

AMGEN Q4 ADJUSTED EPS $5.29 VERSUS IBES ESTIMATE $4.73

AMGEN OUTLOOK FY26 TOTAL REVENUE $37.0 BILLION-$38.4 BILLION VERSUS IBES ESTIMATE $37.08 BILLION

AMGEN Q4 TOTAL REVENUE $9.87 BILLION VERSUS IBES ESTIMATE $9.47 BILLION

AMGEN: PHASE 1 STUDY OF AMG 513 ENROLLING ADULTS LIVING WITH OBESITY

AMGEN: TO INITIATE PHASE 3 STUDIES OF MARITIDE IN PEOPLE LIVING WITH TYPE 2 DIABETES IN 2026

AMGEN OUTLOOK FY26 SHARE REPURCHASES NOT TO EXCEED $3 BILLION

 ((Reuters.Briefs@thomsonreuters.com;))